Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
3'-fluoro-azido-substituted and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside derivatives are potent anti-retrovirus agents — Jan Balzarini (1988) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
3'-fluoro-azido-substituted and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside derivatives are potent anti-retrovirus agents
Shared by
De Clercq Erik
KU Leuven
3'-fluoro-azido-substituted and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside derivatives are potent anti-retrovirus agents
Article
1988
en
Authors
+2 more
JB
Jan Balzarini
MB
Mitsuo Baba
RP
Rudi Pauwels
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1988
Anti-retrovirus activity of 3′-fluoro- and 3′-azido-substituted pyrimidine 2′,3′-dideoxynucleoside analogues
Jan Balzarini
,
Masanori Baba
,
Rudi Pauwels
,
Piet Herdewijn
,
De Clercq Erik
Article
1991
Potent and selective anti-retrovirus activity of 9-(RS)-(3-fluoro-2-phosphonylmethoxypropyl) purine derivatives
Jan Balzarini
,
A. HOLY
,
Jindřich Jindřich
,
Hana Dvořáková
,
Hao Zhang
,
Robert Snoeck
,
Piet Herdewijn
,
David G. Johns
,
De Clercq Erik
Article
1989
5-chloro-substituted derivatives of 2',3'-didehydro-2' ,3'-dideoxyuridine, 3'-fluoro-2' ,3'-dideoxyuridine and 3'-azido-2' ,3'-dideoxyuridine as anti-HIV agents
Jan Balzarini
,
Arthur Van Aerschot
,
Piet Herdewijn
,
De Clercq Erik
Article
1990
Potent and Selective Anti‐HIV Activity of 5‐Chloro‐Substituted Derivatives of 3′‐Azido‐2′,3′‐Dideoxycytidine, 3′‐Fluoro‐2′,3′‐Dideoxycytidine, and 2′,3′‐Didehydro‐2′,3′‐Dideoxycytidine
Jan Balzarini
,
Arthur Van Aerschot
,
Piet Herdewijn
,
De Clercq Erik
Article
1991
Sulphated Cyclodextrins are Potent anti-HIV Agents Acting Synergistically with 2′,3′-dideoxynucleoside Analogues
Dominique Schols
,
De Clercq Erik
,
Myriam Witvrouw
,
Hiroshi Nakashima
,
Robert Snoeck
,
Rudi Pauwels
,
Ann Van Schepdael
,
P. Claes
Discussion(0)
No comments yet. Be the first to comment.